Skip to main content

Addressing oncologists' gaps in the use of biosimilar products.

Publication ,  Journal Article
Williamson, C; Berger, L; Sullivan, TP; Crawford, J; Lyman, GH
Published in: Am J Manag Care
June 2019

Duke Scholars

Published In

Am J Manag Care

EISSN

1936-2692

Publication Date

June 2019

Volume

25

Issue

6 Spec No.

Start / End Page

SP188 / SP191

Location

United States

Related Subject Headings

  • United States
  • Practice Patterns, Physicians'
  • Oncologists
  • Neoplasms
  • Humans
  • Health Policy & Services
  • Education, Medical, Continuing
  • Drug Approval
  • Clinical Competence
  • Biosimilar Pharmaceuticals
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Williamson, C., Berger, L., Sullivan, T. P., Crawford, J., & Lyman, G. H. (2019). Addressing oncologists' gaps in the use of biosimilar products. Am J Manag Care, 25(6 Spec No.), SP188–SP191.
Williamson, Chad, Leanne Berger, Thomas P. Sullivan, Jeffrey Crawford, and Gary H. Lyman. “Addressing oncologists' gaps in the use of biosimilar products.Am J Manag Care 25, no. 6 Spec No. (June 2019): SP188–91.
Williamson C, Berger L, Sullivan TP, Crawford J, Lyman GH. Addressing oncologists' gaps in the use of biosimilar products. Am J Manag Care. 2019 Jun;25(6 Spec No.):SP188–91.
Williamson, Chad, et al. “Addressing oncologists' gaps in the use of biosimilar products.Am J Manag Care, vol. 25, no. 6 Spec No., June 2019, pp. SP188–91.
Williamson C, Berger L, Sullivan TP, Crawford J, Lyman GH. Addressing oncologists' gaps in the use of biosimilar products. Am J Manag Care. 2019 Jun;25(6 Spec No.):SP188–SP191.

Published In

Am J Manag Care

EISSN

1936-2692

Publication Date

June 2019

Volume

25

Issue

6 Spec No.

Start / End Page

SP188 / SP191

Location

United States

Related Subject Headings

  • United States
  • Practice Patterns, Physicians'
  • Oncologists
  • Neoplasms
  • Humans
  • Health Policy & Services
  • Education, Medical, Continuing
  • Drug Approval
  • Clinical Competence
  • Biosimilar Pharmaceuticals